Roche

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. 

CEO
Thomas Schinecker
CEOThomas Schinecker
Employees
112,774
Employees112,774
Headquarters
Basel, Basel-Stadt (Basle Town)
HeadquartersBasel, Basel-Stadt (Basle Town)
Founded
1896
Founded1896
Employees
112,774
Employees112,774

RHHBY Key Statistics

Market cap
393.97B
Market cap393.97B
Price-Earnings ratio
24.66
Price-Earnings ratio24.66
Dividend yield
1.66%
Dividend yield1.66%
Average volume
1.01M
Average volume1.01M
High today
$60.49
High today$60.49
Low today
$60.05
Low today$60.05
Open price
$60.13
Open price$60.13
Volume
87.43K
Volume87.43K
52 Week high
$61.75
52 Week high$61.75
52 Week low
$44.57
52 Week low$44.57

RHHBY News

Investing.com 1d
Roche receives EU committee backing for Gazyva in lupus treatment - Investing.com

...

Roche receives EU committee backing for Gazyva in lupus treatment - Investing.com
TipRanks 1d
Roche announces EMA’s CHMP recommended approval of Gazyva/Gazyvaro

Roche (RHHBY) announced that the European Medicines Agency’s, EMA, Committee for Medicinal Products for Human Use, CHMP, has recommended the approval of Gazyva/...

Analyst ratings

46%

of 24 ratings
Buy
45.8%
Hold
45.8%
Sell
8.3%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.